Olanzapine Viatris (Olanzapine)

Olanzapine works by blocking dopamine D2 receptors and serotonin 5‑HT2A/2C receptors in the brain, while also affecting histamine, muscarinic and adrenergic receptors. This broad receptor antagonism helps to reduce psychotic symptoms and stabilize mood.

The appropriate dose of Olanzapine is individualized and determined by the prescribing healthcare professional based on the patient’s condition, response to therapy and tolerability. No fixed dosing regimen is provided here.

Olanzapine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is excreted in breast milk, so breastfeeding is generally not recommended unless the infant’s benefit outweighs the possible risks.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Olanzapine is classified as an atypical antipsychotic and is often noted for its efficacy in treating both positive and negative symptoms of schizophrenia, as well as mood stabilization in bipolar disorder. Compared with some other atypicals, it may have a higher propensity for metabolic side effects such as weight gain and glucose elevation.

Olanzapine tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and do not use after the expiry date.

Olanzapine Viatris is taken orally, usually once daily, with or without food, as directed by the prescribing clinician. The tablets should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.

Serious risks include neuroleptic malignant syndrome, tardive dyskinesia, severe hyperglycemia or new‑onset diabetes, and leukopenia or agranulocytosis. Patients should seek immediate medical attention if they experience high fever, muscle rigidity, sudden changes in mood, unexplained infections or abnormal blood counts.

Olanzapine is contraindicated in individuals with known hypersensitivity to olanzapine or any of its excipients. Caution is advised for patients with uncontrolled diabetes, severe cardiovascular disease, hepatic impairment, or a history of neuroleptic malignant syndrome.